Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges

PLoS Genetics

Volumn 13, Issue 10, 2017, Pages

  Paternoster, Lavinia ^a   Tilling, Kate ^a   Davey Smith, George ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; GENE IDENTIFICATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; PHENOTYPE; REVIEW; STAGING; CORONARY DISEASE; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; RISK FACTOR;

CORONARY DISEASE; DISEASE PROGRESSION; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; PHENOTYPE; RISK FACTORS;

EID: 85030785935     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006944     Document Type: Review

References (35)

1. Cowan WM, Kopnisky KL, Hyman SE, The human genome project and its impact on psychiatry. Annu Rev Neurosci. 2002;25:1–50. doi: 10.1146/annurev.neuro.25.112701.142853 12052903
2. Obeidat M, Hall IP, Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies. British journal of pharmacology. 2011;163(1):96–105. doi: 10.1111/j.1476-5381.2011.01222.x 21232051
3. Manolio TA, Collins FS, The HapMap and genome-wide association studies in diagnosis and therapy. Annual review of medicine. 2009;60:443–56. doi: 10.1146/annurev.med.60.061907.093117 19630580
4. Gabbani T, Deiana S, Marocchi M, Annese V, Genetic risk variants as therapeutic targets for Crohn's disease. Expert opinion on therapeutic targets. 2017;21(4):381–90. doi: 10.1080/14728222.2017.1296431 28281904
5. National Human Genome Research Institute-European Bioinformatics Institute. Genome-Wide Association Studies catalog. http://www.ebi.ac.uk/gwas/.
6. Munafo MR, Timofeeva MN, Morris RW, Prieto-Merino D, Sattar N, Brennan P, et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. Journal of the National Cancer Institute. 2012;104(10):740–8. doi: 10.1093/jnci/djs191 22534784
7. Lee JC, Biasci D, Roberts R, Gearry RB, Mansfield JC, Ahmad T, et al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet. 2017;49(2):262–8. doi: 10.1038/ng.3755 28067912
8. Kim YI, Role of folate in colon cancer development and progression. J Nutr. 2003;133(11 Suppl 1):3731S–9S. 14608107
9. Williams FM, Popham M, Sambrook PN, Jones AF, Spector TD, MacGregor AJ, Progression of lumbar disc degeneration over a decade: a heritability study. Annals of the rheumatic diseases. 2011;70(7):1203–7. doi: 10.1136/ard.2010.146001 21402564
10. Chataway J., et al. Multiple sclerosis in sibling pairs: an analysis of 250 families. J. Neurol. Neurosurg. Psychiatry2001; 71, 757–761. doi: 10.1136/jnnp.71.6.757 11723196
11. Davey Smith G, Ebrahim S, 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?Int J Epidemiol. 2003;32(1):1–22. 12689998
12. Davey Smith G, Hemani G, Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Human molecular genetics. 2014;23(R1):R89–98. doi: 10.1093/hmg/ddu328 25064373
13. Breitling LP, Koenig W, Fischer M, Mallat Z, Hengstenberg C, Rothenbacher D, et al. Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study. PLoS ONE. 2011;6(7):e22318. doi: 10.1371/journal.pone.0022318 21799821
14. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statistics in medicine. 2008;27(8):1133–63. doi: 10.1002/sim.3034 17886233
15. Boef AG, Dekkers OM, le Cessie S, Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2):496–511. doi: 10.1093/ije/dyv071 25953784
16. Pierce BL, Burgess S, Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177–84. doi: 10.1093/aje/kwt084 23863760
17. Emdin CA, Khera AV, Natarajan P, Klarin D, Zekavat SM, Hsiao AJ, et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease. Jama. 2017;317(6):626–34. doi: 10.1001/jama.2016.21042 28196256
18. Varbo A, Benn M, Davey Smith G, Timpson NJ, Tybjaerg-Hansen A, Nordestgaard BG, Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease. Circulation research. 2015;116(4):665–73. doi: 10.1161/CIRCRESAHA.116.304846 25411050
19. Asvold BO, Bjorngaard JH, Carslake D, Gabrielsen ME, Skorpen F, Davey Smith G, et al. Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway. International journal of epidemiology. 2014;43(5):1458–70. doi: 10.1093/ije/dyu113 24867305
20. C Reactive Protein Coronary Heart Disease Genetics CollaborationWensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;342:d548. doi: 10.1136/bmj.d548 21325005
21. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, et al. Inflammation, insulin resistance, and diabetes—Mendelian randomization using CRP haplotypes points upstream. PLoS Med. 2008;5(8):e155. doi: 10.1371/journal.pmed.0050155 18700811
22. Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE, C-reactive protein and the risk of cancer: a mendelian randomization study. Journal of the National Cancer Institute. 2010;102(3):202–6. doi: 10.1093/jnci/djp459 20056955
23. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. Bmj. 2014;349:g4164. doi: 10.1136/bmj.g4164 25011450
24. Stitziel NO, Kathiresan S, Leveraging human genetics to guide drug target discovery. Trends in cardiovascular medicine. 2016;S1050-1738(16):30128–1.
25. Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. N Engl J Med. 2016;375(22):2144–53. doi: 10.1056/NEJMoa1604304 27959767
26. Mokry LE, Ahmad O, Forgetta V, Thanassoulis G, Richards JB, Mendelian randomisation applied to drug development in cardiovascular disease: a review. Journal of medical genetics. 2015;52(2):71–9. doi: 10.1136/jmedgenet-2014-102438 25515070
27. Munafo MR, Tilling K, Taylor AE, Evans DM, Davey Smith G, Collider Scope: How selection bias can induce spurious associations. Int J Epidemiol, in press.
28. Yaghootkar H, Bancks MP, Jones SE, McDaid A, Beaumont R, Donnelly L, et al. Quantifying the extent to which index event biases influence large genetic association studies. Human molecular genetics. 2017;26(5):1018–30. doi: 10.1093/hmg/ddw433 28040731
29. Martin J, Tilling K, Hubbard L, Stergiakouli E, Thapar A, Davey Smith G, et al. Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study. Am J Epidemiol. 2016;183(12):1149–58. doi: 10.1093/aje/kww009 27188935
30. Balazard F, Le Fur S, Bougnères P, Valleron A-J, the Isis-Diab collaborative groupDisease as collider: a new case-only method to discover environmental factors in complex diseases with genetic risk estimation. BioRxivdoi: 10.1101/1245602017
31. Warrington NM, Howe LD, Paternoster L, Kaakinen M, Herrala S, Huikari V, et al. A genome-wide association study of body mass index across early life and childhood. International journal of epidemiology. 2015;44(2):700–12. doi: 10.1093/ije/dyv077 25953783
32. Warrington NM, Tilling K, Howe LD, Paternoster L, Pennell CE, Wu YY, et al. Robustness of the linear mixed effects model to error distribution assumptions and the consequences for genome-wide association studies. Statistical applications in genetics and molecular biology. 2014;13(5):567–87. doi: 10.1515/sagmb-2013-0066 25153607
33. Tchetgen Tchetgen EJ, Walter S, Vansteelandt S, Martinussen T, Glymour M, Instrumental variable estimation in a survival context. Epidemiology (Cambridge, Mass). 2015;26(3):402–10.
34. Davey Smith G, Paternoster L, Relton C, When Will Mendelian Randomization Become Relevant for Clinical Practice and Public Health?Jama. 2017;317(6):589–91. doi: 10.1001/jama.2016.21189 28196238
35. Hemani G, Zheng J, Wade K, Laurin C, Elsworth B, Burgess S, et al. MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations. BioRxivhttps://doi.org/10.1101/0789722016